Pathware develops integrated hardware and software to bring digital pathology from the central laboratory to the point-of-care. The company's core product pairs imaging hardware with software to enable decentralized pathology workflows. Pathware intends to use its newly raised funds to expand the team and to submit its integrated hardware and software system to the FDA for clearance. The company announced a $7M Series A to support these efforts. Pathware is led by newly named CEO TJ Meyer, who previously led global marketing, strategy, clinical support, and business development at Veran Medical Technologies. During his tenure at Veran, the company grew revenues from $2 million to $30 million and was acquired by Olympus in December 2020.

Total raised

$7M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2022